Details for Patent: 4,767,612
✉ Email this page to a colleague
Summary for Patent: 4,767,612
Title: | Triamcinolone acetonide for the treatment of allergic rhinitis |
Abstract: | Disclosed is a method for the treatment of allergic rhinitis that manifests itself as rhinorrhea, nasal itching, sneezing, congestion and postnasal drip. The method comprises the administration from a nasal aerosol dispenser an effective amount of micronized triamcinolone acetonide suspended in dichlorodifluoromethane into the nasal cavity of a patient suffering from allergic rhinitis. |
Inventor(s): | Hagen; Nicholas S. (Doylestown, PA), Lamon; Kim D. (Maple Glen, PA) |
Assignee: | Rorer Pharmaceutical Corporation (Fort Washington, PA) |
Application Number: | 07/006,397 |
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 4,767,612
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |